Anthem Blue Cross (HMO, PPO, EPO)
Vyxeos (daunorubicin-cytarabine lipos)
Drugs for Cancer : Drugs for Cancer
  • Prior Authorization: Acute Myeloid Leukemia:
    Documented Diagnosis: Yes
    Duration: 1 year(s)

  • Step Therapy: Acute Myeloid Leukemia:
    ST Multiple Generics

  • Acute Myeloid Leukemia:
    Duration: 1 year(s)
    Documented Diagnosis: Yes
    Medical Test Required: No
    Reauthorization Required: No
    Duration of Reauthorization: N/A
    Drug Policy Based On: Payer Specific
    Quantity Limit: N/A
    Diagnosis Types: All FDA-approved indications
    Excludes Coverage in Maintenance Setting: No

  • Available only through Specialty Pharmacy;